Literature DB >> 18258400

Identification of replicative senescence-associated genes in human umbilical vein endothelial cells by an annealing control primer system.

Tae Woo Kim1, Hyun Jung Kim, Chuhee Lee, Hwa Young Kim, Suk-Hwan Baek, Jung Hye Kim, Ki-Sun Kwon, Jae-Ryong Kim.   

Abstract

Cellular senescence is regulated by specific genes in many organisms. The identification and functional analysis of senescence-associated genes could provide valuable insights into the senescence process. Here, we employed a new and improved differential display reverse transcription-polymerase chain reaction (DDRT-PCR) method that involves annealing control primers (ACPs) to identify genes that are differentially expressed in human umbilical endothelial cells during replicative senescence. Using 120 ACPs, we identified 31 differentially expressed genes (DEGs). Basic local alignment search tool (BLAST) search revealed 29 known genes and two unknown genes. Expression levels of the 29 known genes were confirmed by real-time quantitative RT-RCR and by Western blotting for eight of these genes. CD9 antigen, MHC class I chain-related sequence A (MICA) and cell division cycle 37 homolog (CDC37) were up-regulated, and bone morphogenetic protein 4 (BMP4), dickkopf-1 (DKK1), and transcription factor 7-like 1 (TCF7L1) were down-regulated in old cells. Treatment with recombinant human MICA caused a decrease in cell proliferation and an increase in senescence-associated beta-galactosidase staining. Further analysis of differentially expressed genes may provide insights into the molecular basis of replicative senescence and vascular diseases associated with cellular senescence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258400     DOI: 10.1016/j.exger.2007.12.010

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  9 in total

1.  Optimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagents.

Authors:  Michelle A Hunt; Margaret J Currie; Bridget A Robinson; Gabi U Dachs
Journal:  J Biomol Tech       Date:  2010-07

Review 2.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

3.  CD9 induces cellular senescence and aggravates atherosclerotic plaque formation.

Authors:  Jung Hee Cho; Eok-Cheon Kim; Youlim Son; Da-Woon Lee; Yong Seop Park; Joon Hyuk Choi; Kyung-Hyun Cho; Ki-Sun Kwon; Jae-Ryong Kim
Journal:  Cell Death Differ       Date:  2020-04-28       Impact factor: 15.828

4.  A platform for reverse genetics in endothelial cells.

Authors:  Fatma O Kok; Nathan D Lawson
Journal:  Circ Res       Date:  2015-07-03       Impact factor: 17.367

5.  CD9 expression in vascular aging and atherosclerosis.

Authors:  Jae-Ryong Kim; Joon Hyuk Choi
Journal:  Histol Histopathol       Date:  2020-10-07       Impact factor: 2.303

6.  NKG2D ligands mediate immunosurveillance of senescent cells.

Authors:  Adi Sagiv; Dominick G A Burton; Zhana Moshayev; Ezra Vadai; Felix Wensveen; Shifra Ben-Dor; Ofra Golani; Bojan Polic; Valery Krizhanovsky
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

Review 7.  Senotherapeutics: emerging strategy for healthy aging and age-related disease.

Authors:  Eok-Cheon Kim; Jae-Ryong Kim
Journal:  BMB Rep       Date:  2019-01       Impact factor: 4.778

8.  Endothelial cell senescence is associated with disrupted cell-cell junctions and increased monolayer permeability.

Authors:  Vincent J D Krouwer; Liesbeth H P Hekking; Miriam Langelaar-Makkinje; Elsa Regan-Klapisz; Jan Andries Post
Journal:  Vasc Cell       Date:  2012-08-28

9.  Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF.

Authors:  Elizabeth C Wahl; James Aronson; Lichu Liu; John L Fowlkes; Kathryn M Thrailkill; Robert C Bunn; Robert A Skinner; Mike J Miller; Gael E Cockrell; Lindsey M Clark; Yang Ou; Carlos M Isales; Thomas M Badger; Martin J Ronis; John Sims; Charles K Lumpkin
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.